End-stage periventricular leukomalacia: MR evaluation.

Area of Science:

• Pediatric neurology
• Neuroradiology
• Medical imaging

Background:

• Periventricular leukomalacia (PVL) is a significant cause of neurologic impairment in infants.
• Neonatal ultrasonography can document PVL, but its utility in assessing end-stage disease is limited.
• Advanced neuroimaging is crucial for characterizing long-term sequelae of neonatal brain injury.

Purpose of the Study:

• To evaluate the capabilities of magnetic resonance (MR) imaging in assessing end-stage periventricular leukomalacia (PVL).
• To identify characteristic MR imaging findings associated with established PVL.
• To correlate MR imaging findings with the degree of neurologic impairment in affected children.

Main Methods:

• Prospective study involving six children (31-54 months) with documented neonatal PVL.
• Comparison with eight age-matched healthy children serving as controls.
• Detailed analysis of MR imaging features, including signal intensity, white matter loss, and ventricular changes, using T2-weighted sequences.

Main Results:

• A characteristic triad of MR findings for PVL was identified: increased periventricular white matter signal intensity, marked white matter loss, and compensatory focal ventricular enlargement.
• These abnormalities were most commonly observed in the trigone regions of the lateral ventricles.
• A general correlation was found between the severity of MR abnormalities and the degree of neurologic impairment.

Conclusions:

• MR imaging is a valuable tool for evaluating end-stage periventricular leukomalacia in children.
• It can detect subtle forms of PVL and subclinical neurologic damage.
• The characteristic MR imaging triad aids in diagnosis and prognosis assessment.